Patrick Harrison Carroll - 14 Mar 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Medical Officer, Director
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
14 Mar 2025
Net transactions value
-$903,766
Form type
4
Filing time
18 Mar 2025, 18:35:38 UTC
Previous filing
05 Mar 2025
Next filing
16 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +36,275 +18% 236,110 14 Mar 2025 Direct F1
transaction HIMS Class A Common Stock Tax liability $104,789 -3,162 -1.3% $33.14 232,948 14 Mar 2025 Direct F2
transaction HIMS Class A Common Stock Sale $798,977 -23,287 -10% $34.31 209,661 18 Mar 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -8,148 -12% $0.000000 57,041 14 Mar 2025 Class A Common Stock 8,148 Direct F1, F4
transaction HIMS Restricted Stock Unit Options Exercise $0 -4,840 -7.7% $0.000000 58,075 14 Mar 2025 Class A Common Stock 4,840 Direct F1, F5
transaction HIMS Restricted Stock Unit Options Exercise $0 -23,287 -100% $0.000000 0 14 Mar 2025 Class A Common Stock 23,287 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
F3 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 8, 2024 by the Reporting Person
F4 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter.
F5 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
F6 The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2023, (ii) one-third of the RSUs vesting on March 15, 2024 and (iii) one-third of the RSUs vesting on March 15, 2025.